Hayleigh Collins

Hayleigh Collins has a diverse background in corporate communications and brand communications. Hayleigh is currently the Director and Head of Corporate Communications at Taysha Gene Therapies since March 2023. Prior to that, they worked at Jaguar Gene Therapy as a Senior Manager of Corporate Communications from August 2022 to March 2023, and as a Corporate Communications Manager from January 2021 to August 2022. Hayleigh also gained experience at Horizon as a Brand Communications Contract Employee from August 2020 to February 2021, and as a Brand Communications Intern from June 2020 to August 2020. Additionally, they worked at AveXis, Inc. as a Corporate Communications Intern in May 2019 and July 2019, where they contributed to the successful launch of a gene therapy product. Hayleigh's background also includes an internship at W2O Group as a Pricing & Value Account Intern from June 2018 to August 2018, where they assisted in generating reports and leading a digital marketing campaign.

Hayleigh Collins attended Texas Christian University from 2016 to 2020. Hayleigh earned a Bachelor of Science degree in Strategic Communication and Business.